ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
10.80
+0.20 (1.84%)
Sep 4, 2025, 4:00 PM - Market closed

ORIC Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2020
Net Income
-137.25-127.85-100.7-89.12-78.72-73.7
Upgrade
Depreciation & Amortization
1.191.111.030.970.90.97
Upgrade
Loss (Gain) From Sale of Assets
--0.020.040-
Upgrade
Asset Writedown & Restructuring Costs
-----19.84
Upgrade
Loss (Gain) From Sale of Investments
-5.05-8.1-6.17-1.041.350.3
Upgrade
Stock-Based Compensation
23.3920.2115.2314.4612.855.28
Upgrade
Change in Accounts Payable
-4.381.833.28-1.482.934.3
Upgrade
Change in Other Net Operating Assets
1.880.141.621.031.14-2.26
Upgrade
Operating Cash Flow
-120.23-112.66-85.69-75.14-59.54-45.27
Upgrade
Capital Expenditures
-1.09-1.19-0.85-2.08-0.94-0.67
Upgrade
Investment in Securities
12.3323.33-42.55-107.17159.37-215.49
Upgrade
Other Investing Activities
-----0.19
Upgrade
Investing Cash Flow
11.2522.14-43.4-109.25158.44-215.96
Upgrade
Issuance of Common Stock
135.67126.7285.8925.6250.99271.75
Upgrade
Other Financing Activities
-0.66-0.17-0.23-0.4-1.85-21.24
Upgrade
Financing Cash Flow
135.01126.5585.6625.2349.13250.51
Upgrade
Net Cash Flow
26.0336.02-43.43-159.17148.03-10.71
Upgrade
Free Cash Flow
-121.31-113.85-86.54-77.22-60.48-45.94
Upgrade
Free Cash Flow Per Share
-1.67-1.63-1.68-1.95-1.59-2.09
Upgrade
Levered Free Cash Flow
-72.47-67.1-49.08-42.02-32.71-23.87
Upgrade
Unlevered Free Cash Flow
-72.47-67.1-49.08-42.02-32.71-23.87
Upgrade
Change in Working Capital
-2.51.974.9-0.454.072.05
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q